Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by wussyon Mar 01, 2021 2:16pm
252 Views
Post# 32686905

RE:RE:Hmmmm

RE:RE:Hmmmm
Power Growth Investor, in the February, 2021, issue, refreshes its buy of Vivo Cannabis Inc., recently 21.5 cents. Power Growth said buy in March, 2020, at 38 cents and in December, 2020, at 12 cents. Assuming a $1,000 investment for each of the two buys, the $2,000 position is now worth $2,357. Vivo grows premium cannabis in Canada. The company recently entered the Quebec market with its "BC Kief" product, the province's first offering in the kief category. Kief is concentrated resin collected from cannabis flowers and leaves. Meanwhile, in Ontario, Vivo has the top market share (38 per cent) in the concentrates category. The stock remains a speculative buy for aggressive investors.
<< Previous
Bullboard Posts
Next >>